Rapport Therapeutics, Inc. (RAPP)
NGM – Real vaqt narxi. Valyuta: USD
37.24
-1.19 (-3.10%)
Yopilishda: May 12, 2026, 4:00 PM EDT
37.24
0.00 (0.00%)
Bozordan keyin: May 12, 2026, 4:10 PM EDT
Find any stock by ticker or company name

NGM – Real vaqt narxi. Valyuta: USD
37.24
-1.19 (-3.10%)
Yopilishda: May 12, 2026, 4:00 PM EDT
37.24
0.00 (0.00%)
Bozordan keyin: May 12, 2026, 4:10 PM EDT
Rapport Therapeutics, Inc. markaziy asab tizimi (CNS) kasalliklaridan aziyat chekayotgan bemorlar uchun transformatsion kichik molekulali dorilarni kashf qilish va ishlab chiqishga qaratilgan klinik bosqichdagi biofarmatsevtika kompaniyasi sifatida faoliyat yuritadi. Kompaniyaning asosiy mahsulot nomzodi TARPy8-ni o'z ichiga olgan AMPARlarni pikomolyar yaqinlik bilan inhibe qilish uchun mo'ljallangan, fokal epilepsiya va periferik neyropatik og'riq hamda bipolyar buzuqlikni o'z ichiga olgan boshqa CNS kasalliklarini davolash uchun mo'ljallangan tadqiqot kichik molekulasi bo'lgan retseptor bilan bog'liq oqsil (RAP)-219 hisoblanadi. Shuningdek, u surunkali og'riq va migrenni davolash uchun a6 nAChR; va eshitish/vestibulyar kasalliklarni davolash uchun a9a10 nAChR kabi nikotinik asetilxolin retseptorlari (nAChR) dasturlarini ishlab chiqadi. Kompaniya ilgari Precision Neuroscience NewCo, Inc. nomi bilan tanilgan va 2022 yil oktyabr oyida Rapport Therapeutics, Inc. nomini o'zgartirgan. Rapport Therapeutics, Inc. 2022 yilda tashkil etilgan va Boston, Massachusetsda joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. David Bredt M.D., Ph.D. | Founder & Chief Scientific Officer |
| Dr. Jeffrey Sevigny M.D. | Chief Medical Officer |
| Dr. Steven M. Paul M.D. | Founder & Independent Chairman |
| Dr. Troy A. Ignelzi | Chief Financial Officer |
| Mr. Abraham N. Ceesay M.B.A. | CEO, President, Treasurer & Director |
| Mr. Swamy Yeleswaram Ph.D. | Chief Development Officer |
| Ms. Cheryl Gault | Chief Operating Officer |
| Ms. Julie DiCarlo | Head of Communications & Investor Relations |
| Ms. Karina Chmielewski | Chief Information Officer & Head of Operations |
| Ms. Kathleen A. Wilkinson | Chief People Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-07 | 10-Q | rapp-20260331.htm |
| 2026-04-23 | DEFA14A | d96029ddefa14a.htm |
| 2026-04-23 | DEF 14A | d35380ddef14a.htm |
| 2026-04-23 | ARS | d21303dars.pdf |
| 2026-04-21 | 8-K | rapp-20260421.htm |
| 2026-03-10 | S-3ASR | d46288ds3asr.htm |
| 2025-11-06 | 10-Q | rapp-20250930.htm |
| 2025-09-10 | 8-K | d907117d8k.htm |
| 2025-08-07 | 10-Q | rapp-20250630.htm |
| 2025-07-07 | CORRESP | filename1.htm |